Navigation Links
Upgraded ACCF/ AHA/ SCAI Guidelines Reinforce Benefits of Volcano's Precision Guided Therapy Technologies
Date:11/9/2011

ic heart disease.

The guidelines also included that every PCI program should participate in a regional or national PCI registry for the purpose of benchmarking its outcomes against current national norms. Technologies like IVUS and FFR help physicians make more informed clinical decisions and can have a positive impact on the quality scores of a healthcare institution.

About Volcano Corporation

Volcano Corporation is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information—using light and sound as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together. For more information, visit the company's website at www.volcanocorp.com.  

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995.  Any statements in this release that are not historical facts may be considered "forward-looking statements." Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties which may cause Volcano's results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ include the pace and extent of market adoption of the company's products and technologies, growth strategies, timing and achievement of product development milestones, the impact and benefits of market development, product introductions, unexpected new data, safety and technic
'/>"/>

SOURCE Volcano Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cardiogenesis (CGCP) Listing Upgraded to New OTCQB(TM) Market for All U.S. Registered and Reporting OTC Securities
2. Daiichi Sankyo/Lilly Respond to ACCF/AHA Clinical Alert on Antiplatelet Therapy
3. Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction
4. 2011 ACCF/AHA Guidelines Incorporate New Recommendation for Platelet Reactivity Testing
5. Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)
6. DHHS Guidelines Support Use of Trofile(TM) Assay Prior to CCR5 Inhibitor Use
7. New Guidelines: Antibiotic Prophylaxis
8. ACR Supports American Cancer Society Inclusion of CT Colonography (Virtual Colonoscopy) as Recommended Screening Tool for Colorectal Cancer in New Screening Guidelines
9. Lung Cancer Alliance Commends NCCN on Screening Guidelines
10. Published Guidelines Further Support Use of Bioimpedance Measurement Technology for Early Assessment of Lymphedema
11. Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 Adaptive Biotechnologies, a clinical stage diagnostics ... the adaptive immune system, is pleased to announce the ... Officer (CCO). The addition of Brain to the Company,s ... leading global healthcare companies, including Dean Schorno ... Genomic Health and Sean Nolan (CTO) from ...
(Date:9/16/2014)... QPID Health , a leader in clinical intelligence software, ... Boston and their first West Coast location in ... Street in Boston , and will house product ... Southern California office will be located at ... the demands of customers nationwide.  Both new locations will be ...
(Date:9/16/2014)... Sept. 16, 2014  Formex, LLC ("Formex"), ... that Mr. Greg Weilersbacher joined Formex as Director ... Greg Weilersbacher has ... focused expertise in Quality Assurance, Facility Validation, ... Weilersbacher brings to Formex a diverse wealth ...
Breaking Medicine Technology:Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 2Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 3QPID Health Announces Major Office Expansion in Boston and Opens Facility in San Diego 2Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control 2
... R.I., Aug. 16, 2011 Medicare Part D beneficiaries ... pay 100 percent of previously subsidized prescription costs, are ... are to switch to more affordable or generic medications, ... concludes. (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO) The ...
... Savient Pharmaceuticals, Inc. (NASDAQ: SVNT ) ... Phase III clinical studies in patients with refractory chronic ... of the American Medical Association ( JAMA ). ... significant and sustained reductions in uric acid levels along ...
Cached Medicine Technology:CVS Caremark, Harvard and Brigham and Women's Researchers Say Medicare 'Donut Hole' Can Lead to a Decrease in Medication Adherence 2CVS Caremark, Harvard and Brigham and Women's Researchers Say Medicare 'Donut Hole' Can Lead to a Decrease in Medication Adherence 3Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 2Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 3Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 4Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 5Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 6Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 7Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 8
(Date:9/16/2014)... New York (PRWEB) September 16, 2014 ... Pinnacle hip replacement lawsuit ( http://www.consumerinjurylawyers.com/depuy-pinnacle/lawsuit ) now ... of Texas has moved into its third week, ... this week’s witnesses included a DePuy Orthopaedics vice ... performed on the metal-on-metal Pinnacle hip. * (Herlihy-Paoli ...
(Date:9/16/2014)... School of Medicine have launched a phase 1 human ... a new monoclonal antibody for patients with chronic lymphocytic ... in adults. , The new antibody targets ... development and exploited by cancer cells to promote tumor ... of all cancer-related deaths. , Because ROR1 ...
(Date:9/16/2014)... 16, 2014 RxAnte, the leading ... and targeted clinical programs, today announced key changes ... the Company’s drive to improve medication effectiveness through ... programs. On September 2, 2014, Brock Hardaway, chief ... announced that RxAnte founder and President Josh Benner ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Former Major ... today after undergoing successful heart transplantation surgery at Allegheny ... Tekulve, who spent most of his 16-year baseball career ... as a commentator for Root Sports Pittsburgh, was discharged ... surgeon, Stephen Bailey, MD, surgical director of AGH’s heart ...
(Date:9/16/2014)... no longer be used to ascertain the eventual scale ... University of Warwick. , Dr Thomas House, of the ... data from past outbreaks that successfully replicated their eventual ... Ebola Outbreaks and published by eLife , shows ... 2014 outbreak to the model that it is, according ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Latest Testimony in Federal Pinnacle Hip Replacement Trial 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Latest Testimony in Federal Pinnacle Hip Replacement Trial 3Health News:Novel drug targeting leukemia cells enters clinical trial 2Health News:Millennium Health’s RxAnte Subsidiary Announces Leadership Promotions 2Health News:Millennium Health’s RxAnte Subsidiary Announces Leadership Promotions 3Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 2Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 3Health News:Ebola outbreak 'out of all proportion' and severity cannot be predicated 2
... of the outcomes of medical tests whose results are ... is common and can lead to serious medical errors ... by researchers from the Regenstrief Institute and the Indiana ... summaries are grossly inadequate at documenting both tests with ...
... - Hard to Treat Diseases, Inc. (HTDS:PK), ( http://www.htdsmedical.com ... (Mellow Hope) announced today that the general manager of ... to a significant new business development opportunity related to ... to participate in a formal tender process to supply ...
... , JEDDAH, Saudi Arabia, Aug. 7 ... about themselves, and Saudi women are no exception. But is ... strong guiding force in the kingdom? Read about how plastic ... , http://susiesbigadventure.blogspot.com/2009/08/plastic-surgery-in-saudi-arabia.html , ...
... if fall outbreak proves more severe, government says , ... that swept across the United States last spring during ... repeated this fall, according to new guidelines issued Friday ... noted that everything could change if the outbreak suddenly ...
... Aug. 7 Pharmaceutical Institute, a leading provider of specialized ... that Garry O,Grady has been appointed Senior Vice President and ... Mr. O,Grady will manage the day-to-day operations of the business, ... and sales teams. , , Mr. O,Grady ...
... , , NEW YORK, Aug. 7 ... need additional vaccines beyond those received when they were infants or ... (CDC) estimates, most pre-teens and teens do not have all the ... risks for certain diseases and protection from some childhood vaccines can ...
Cached Medicine News:Health News:Fumbled handoffs can lead to medical errors 2Health News:Hard To Treat Diseases (HTDS) Chile Flu Vaccine Tender 2Health News:Hard To Treat Diseases (HTDS) Chile Flu Vaccine Tender 3Health News:Hard To Treat Diseases (HTDS) Chile Flu Vaccine Tender 4Health News:School Closures May Not Be Necessary When Swine Flu Strikes 2Health News:School Closures May Not Be Necessary When Swine Flu Strikes 3Health News:School Closures May Not Be Necessary When Swine Flu Strikes 4Health News:Garry O'Grady Appointed Senior Vice President and General Manager of Pharmaceutical Institute 2Health News:Photo: New Survey Results Show Most Moms Are Aware Their Pre-teens and Teens Need Vaccines 2Health News:Photo: New Survey Results Show Most Moms Are Aware Their Pre-teens and Teens Need Vaccines 3
ACMI™ COAG Bipolar Laparoscopy Probes provide 360 of hemostatis, bipolar safety, blunt dissection, irrigation, and suction in one instrument....
An In Vitro Nucleic Acid Hybridization Assay with Signal Amplification using Microplate Chemiluminescence for the Qualitative Detection of Human Papillomavirus (HPV) Types 16, 18, 31, 33, 35, 39, 45,...
... first time in the world, there is a ... to diagnose VVC in female patients. CanDia5® is ... detect the Candida antigens almost instantaneously (within 5 ... blood. There is no similar POC product for ...
... test for Candida albicans in only ... utilizes two enzyme color reactions to ... to read. AlbiQuicktm is performed on ... wells. Incubation time is only five ...
Medicine Products: